Myocardial Calcium Handling in Type 2 Diabetes: A Novel Therapeutic Target

被引:1
|
作者
Dattani, Abhishek [1 ]
Singh, Anvesha
Mccann, Gerry P.
Gulsin, Gaurav S.
机构
[1] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, England
关键词
diabetes; calcium handling; manganese-enhanced MRI; GLYCATION END-PRODUCTS; SARCOPLASMIC-RETICULUM CA2+-ATPASE; CONGESTIVE-HEART-FAILURE; DIASTOLIC DYSFUNCTION; VENTRICULAR MYOCYTES; CARDIAC STRUCTURE; GENE-EXPRESSION; MANGANESE IONS; YOUNG-ADULTS; CARDIOMYOPATHY;
D O I
10.3390/jcdd11010012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes (T2D) is a multisystem disease with rapidly increasing global prevalence. Heart failure has emerged as a major complication of T2D. Dysregulated myocardial calcium handling is evident in the failing heart and this may be a key driver of cardiomyopathy in T2D, but until recently this has only been demonstrated in animal models. In this review, we describe the physiological concepts behind calcium handling within the cardiomyocyte and the application of novel imaging techniques for the quantification of myocardial calcium uptake. We take an in-depth look at the evidence for the impairment of calcium handling in T2D using pre-clinical models as well as in vivo studies, following which we discuss potential novel therapeutic approaches targeting dysregulated myocardial calcium handling in T2D.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] High Density Lipoprotein: A Therapeutic Target in Type 2 Diabetes
    Barter, Philip J.
    ENDOCRINOLOGY AND METABOLISM, 2013, 28 (03) : 169 - 177
  • [22] Sirtuin 6, a possible therapeutic target for type 2 diabetes
    Eun Ju Bae
    Archives of Pharmacal Research, 2017, 40 : 1380 - 1389
  • [23] Abnormal mechanical function in diabetes: Relation to myocardial calcium handling
    Schaffer, SW
    Mozaffari, M
    CORONARY ARTERY DISEASE, 1996, 7 (02) : 109 - 115
  • [24] GPR35 is a potential therapeutic target for myocardial remodeling induced by type 2 diabetes mellitus with hyperuricemia
    Jin, Ranyang
    He, Hongye
    Yang, Yongjian
    Pei, Haifeng
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C6 - C6
  • [25] Novel targets and therapeutic strategies for type 2 diabetes
    Morral, N
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2003, 14 (04): : 169 - 175
  • [26] Novel therapeutic strategies for the treatment of type 2 diabetes
    Perfetti, R
    Barnett, PS
    Mathur, R
    Egan, JM
    DIABETES-METABOLISM REVIEWS, 1998, 14 (03): : 207 - 225
  • [27] Impaired myocardial calcium handling in people with type 2 diabetes: an in vivo manganese-enhanced magnetic resonance imaging study
    Dattani, A.
    Gulsin, G. S.
    Yeo, J. L.
    Joshi, S.
    Singh, A.
    Brady, E. M.
    Parke, K. S.
    Arnold, J. R.
    Singh, T.
    Kershaw, L. E.
    Spath, N. B.
    Semple, S. I.
    Dweck, M. R.
    Newby, D. E.
    McCann, G. P.
    EUROPEAN HEART JOURNAL, 2022, 43 : 230 - 230
  • [28] Emerging opportunities to target inflammation: myocardial infarction and type 2 diabetes
    Kufazvinei, Tafadzwa T. J.
    Chai, Jason
    Boden, Katherine A.
    Channon, Keith M.
    Choudhury, Robin P.
    CARDIOVASCULAR RESEARCH, 2024, 120 (11) : 1241 - 1252
  • [29] Endoplasmic reticulum as a therapeutic target in type 2 diabetes: Role of phytochemicals
    Sajadimajd, Soraya
    Deravi, Niloofar
    Forouhar, Kimia
    Rahimi, Roja
    Kheirandish, Ali
    Bahramsoltani, Roodabeh
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 114
  • [30] PTPN2, a potential therapeutic target for type 1 diabetes?
    Liu, Shan-Shan
    Lou, Ji-Quan
    Ding, Ye
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2014, 58 (09) : 978 - 979